摘要
Purpose: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The malignant biological behavior of HCC is closely related to epithelial-mesenchymal transition (EMT), and EMT plays an important role in the progression, migration and metastasis of HCC. P21-activated kinase 3 (PAK3) is a serine/threonine protein kinase, and PAK3 affects the EMT, proliferation, metastasis and invasion of HCC. Methods: In this study, the relationship between PAK3 and HCC was first analyzed by bioinformatics, and then, the expression of PAK3 in clinical samples was detected by immunohistochemistry (IHC), quantitative real-time PCR (qRT-PCR) and Western blotting. Subsequently, the expression of PAK3 was further confirmed in HCC cells. In addition, after the overexpression or knockdown of PAK3 in cells, the proliferation, migration and invasion abilities of these cells were assessed by Cell Counting Kit-8 (CCK-8), wound healing and Transwell assays, and the results were confirmed in vivo experiments in mice. In addition, we also verified that PAK3 affected the EMT and EMT-related pathway of HCC through qRT-PCR, Western blotting and immunofluorescence experiments. Results: Through database analysis, we found that PAK3 was highly expressed in HCC patients and was positively correlated with tumor stage and grade, suggesting that PAK3 expression was closely related to HCC occurrence and development. We subsequently confirmed that PAK3 was overexpressed in HCC clinical samples and HCC cell lines and that PAK3 promoted the proliferation, migration and invasion of HCC cells in vitro. Finally, we found that PAK3 regulated EMT-related molecule expression and EMT-related TGF-beta/smad signaling pathway. Conclusion: High expression of PAK3 enhances the invasion of HCC and regulates EMT, suggesting that PAK3 may be a potential target for the treatment of HCC.
学科与关键词
- Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular CarcinomaXu, Weikang; Lu, Xinyu; Liu, Jing; Chen, Qianhui; Huang, Xuan; Huang, Kuiyuan; Liu, Hongyan*; Zhu, Wei*; Zhang, Xiaoyong*Frontiers in Oncology, 2021, 11.被引 4
- MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4)Xue Jing; Chen Li Zhang*; Li Zhan Zhan; Hu Ying yun; Yan Shi peng; Liu Li YaMolecular and Cellular Biochemistry, 2015, 399(1-2): 77-86.
- MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axisDian, Mei-Juan; Li, Jing; Zhang, Xiao-Ling; Li, Zi-Jian; Zhou, Ying; Zhou, Wei; Zhong, Qiu-Ling; Pang, Wen-Qian; Lin, Xiao-Lin; Liu, Tao; Liu, Yi-An; Li, Yong-Long; Han, Liu-Xin; Zhao, Wen-Tao; Jia, Jun-Shuang; Xiao, Sheng-Jun; Xiao, Dong*; Xia, Jia-Wei*; Hao, Wei-Chao*American Journal of Cancer Research, 2021, 12(15): 4463-4477.被引 16
